Works matching IS 0741238X AND DT 2025 AND VI 42 AND IP 8


Results: 32
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    20
    21

    Multiple Switches Between Adalimumab-fkjp and Reference Adalimumab in Moderate-to-Severe Chronic Plaque Psoriasis: A Multicenter, Double-Blind, Parallel Group, Randomized Clinical Trial for Interchangeability.

    Published in:
    Advances in Therapy, 2025, v. 42, n. 8, p. 3795, doi. 10.1007/s12325-025-03240-5
    By:
    • Deodhar, Sarika;
    • Loganathan, Subramanian;
    • Kadadanamari Subbarama Reddy, Ramesh;
    • Ranganna, Gopinath M.;
    • Liu, Shiyao;
    • Hummel, Matthew A.;
    • Daniluk, Stefan;
    • Hanczewska, Anna;
    • Vekovska, Kamelia;
    • Zegadlo-Mylik, Maria;
    • Pulka, Grazyna;
    • -Holz, Elena Wolff
    Publication type:
    Article
    22
    23
    24
    25
    26

    Sustained Effectiveness, Tolerability, and Safety of Long-Term Prophylaxis with Lanadelumab in Hereditary Angioedema: The Prospective, Phase 4, Noninterventional EMPOWER Real-World Study.

    Published in:
    Advances in Therapy, 2025, v. 42, n. 8, p. 3882, doi. 10.1007/s12325-025-03226-3
    By:
    • Bernstein, Jonathan A.;
    • Betschel, Stephen D.;
    • Busse, Paula J.;
    • Banerji, Aleena;
    • Wedner, H. James;
    • Manning, Michael;
    • Zaragoza-Urdaz, Rafael H.;
    • Anderson, John;
    • Gagnon, Remi;
    • Baptist, Alan P.;
    • Soteres, Daniel;
    • Lumry, William R.;
    • Craig, Timothy;
    • Petroni, Daniel;
    • Hsu, F. Ida;
    • Nova Estepan, Daniel;
    • Juethner, Salomé;
    • Watt, Maureen;
    • Khutoryansky, Natalie;
    • Zuraw, Bruce L.
    Publication type:
    Article
    27
    28
    29
    30
    31
    32